Blog

Archive for the ‘Jim’s Stock Alerts’ Category

Sort alerts by: Date | Company Name
Acadia Pharmaceuticals (ACAD)

Analyst upgrade is catalyst for 6.17% jump in Acadia Pharmaceuticals today

 Stifel analyst Paul Matteis upgraded Acadia Pharmaceuticals (ACAD) to a Buy from a Hold today and raised his target price to $71 from $41. (Shares closed at $57 today, up 6.17%) The upgrade from Matteis was especially powerful since he has been skeptical on the stock and the potential for its primavanserin to win approval for […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Invesco Currency Shares (FXY)

Selling Japanese yen ETF out of Jubak Picks Portfolio

A while back I sold the Invesco Currency Shares Japanese Yen ETF (FXY) out of my Perfect Five ETF Portfolio because I was looking for more diversification in that limited five ETF portfolio. (I replaced it with the iShares Large Cap China ETF (FXI) on April 20, 2020. That ETF is up 6.51% as of […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Salesforce (CRM)

Selling Salesforce out of my Jubak Picks Portfolio as shares hit target price

Salesforce (CRM) has hit my $185 a share target price. I'm selling it out of my Jubak Picks Portfolio with a 37.42% gain since I added that position back on November 1, 2018. Why sell rather than up the target price? A couple of four reasons for what amounts to taking a breather on these […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Incyte (INCY)

Raising my target price on Incyte to $120 a share after 58.5% gain in last 3 months

I admit it. I feel silly talking about price targets and valuations in this market. After all everything is just going to the sky. Infinity and Beyond!!! But, as silly as I may feel, I don't think the gods of investing have repealed the laws of valuation. At some point--when, only the world's central bankers […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Delta Air Lines (DAL)

Delta Air Lines says it expects to break even by next spring

This is the good news? Delta Air Lines (DAL) said today that it expects to break even by the spring of 2021. Delta, which said it will add 1,000 flights to its schedule in July and again in August, plans to operate 30% of its 2019 schedule by the end of September. “We’re at 15% […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Palo Alto Networks (PANW)

Palo Alto Networks gets modest earnings forecast bump for 2020

Analysts have raised their earnings estimate for cyber-security software company Palo Alto Networks (PANW) by 4.5% to 6.5% (depending on the data source you use) over the last 60 days. For 2020 Wall Street is now looking for $4.79 a share for 2020. That would still be down from the $5.45 the company earned in […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Xylem (XYL)

My Stock Pick of the Day: Xylem (XYL)

Xylem (XYL) is that rare coin on raw market--a pure play water stock at a time when foresighted investors are looking for water stocks and realizing how few of them exist. (The basic water story is that Mother Nature isn't making more of it. Rising global populations need more of it. And human beings are […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Meituan Dianping (MPNGF)

Meituan Dianping shares up 17% today on earnings report

As of 1 p.m. New York time today Meituan Dianping (MPNGF) shares were up 17.52% after the company reported better than forecast sales of 16.8 billion yuan ($2.4 billion) for the quarter that ended on Mach 31. The company reported a lower than projected loss of 1.58 billion yuan ($221 million.) Year over year revenue […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

()

Hanesbrands is a prime example of the dividend dilemma right now–keeping it in Dividend Portfolio despite loss

No doubt about it--looking at the loss in my position in Hanesbrands (HBI) of 37.66% since I added it to my Dividend Portfolio on February 21, 2020 isn't pleasant. But since I hold this stock for its dividend payout, the gain/loss at the moment isn't the only important element in a decision to hold/sell these […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

General Motors (GM)

Selling GM out of my Dividend Portfolio

On April 27, General Motors (GM) suspended its quarterly dividend. It's a smart move to save cash--about $1.6 billion in the remainder of 2020--but without a dividend the stock doesn't deserve a place in a dividend portfolio. I've waited for the dust to clear on that news as the stock had been in a modest […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.